United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others
NEW YORK, Sept. 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0611606/United-States-Cardiovascular-Devices-Market-Outlook-to-2017---Cardiac-Rhythm-Management-Interventional-Cardiology-Peripheral-Vascular-Devices-Prosthetic-Heart-Valves-Electrophysiology-and-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices
United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others
Summary
GlobalData’s new report, “United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others” provides key market data on the United States Cardiovascular Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories – Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Cardiovascular Devices market categories – Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within 10 market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the 10 market categories.
- Global corporate-level profiles of key companies operating within the United States Cardiovascular Devices market.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation, C. R. Bard, Inc. and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United States Cardiovascular Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 17
1.2 List of Figures 24
2 Introduction 29
2.1 What is This Report About? 29
3 Cardiovascular Devices In United States 30
3.1 Cardiovascular Devices, United States, Overall Revenue ($m), 2003-2017 30
3.2 Cardiovascular Devices Market, United States, Revenue Mix ($m), 2010 32
3.3 Cardiovascular Devices Market, United States, Category Contribution (%), 2010 33
3.4 Cardiovascular Devices, United States, Category Volume (Units), 2003-2017 40
3.5 Cardiovascular Devices, United States, Company Share (2009-2010) 46
4 Cardiac Assist Devices In United States 48
4.1 Cardiac Assist Devices, Market Segmentation 48
4.2 Cardiac Assist Devices Market, United States, Revenue Mix ($m), 2010 49
4.3 Cardiac Assist Devices Market, United States, Segment Contribution (%), 2010 50
4.4 Cardiac Assist Devices, Overall Revenue (2003-2017) 51
4.4.1 Intra-Aortic Balloon Pumps Revenue (2003-2017) 55
4.4.2 Ventricular Assist Devices Revenue (2003-2017) 59
4.5 Cardiac Assist Devices Overall Volume (2003-2017) 63
4.5.1 Intra-Aortic Balloon Pumps Volume (2003-2017) 67
4.5.2 Ventricular Assist Devices Volume (2003-2017) 71
4.6 Cardiac Assist Devices Average Price (2003-2017) 75
4.7 Cardiac Assist Devices Distribution Share (2009-2010) 77
4.8 Cardiac Assist Devices, United States, Company Share (2009-2010) 78
5 Cardiac Rhythm Management In United States 80
5.1 Cardiac Rhythm Management, Market Segmentation 80
5.2 Cardiac Rhythm Management Market, United States, Revenue Mix ($m), 2010 81
5.3 Cardiac Rhythm Management Market, United States, Segment Contribution (%), 2010 82
5.4 Cardiac Rhythm Management Overall Revenue (2003-2017) 83
5.4.1 Cardiac Resynchronisation Therapy Revenue (2003-2017) 87
5.4.2 Implantable Cardioverter Defibrillators Revenue (2003-2017) 91
5.4.3 Pacemakers Revenue (2003-2017) 95
5.5 Cardiac Rhythm Management Overall Volume (2003-2017) 99
5.5.1 Cardiac Resynchronisation Therapy Volume (2003-2017) 103
5.5.2 Implantable Cardioverter Defibrillators Volume (2003-2017) 107
5.5.3 Pacemakers Volume (2003-2017) 111
5.6 Cardiac Rhythm Management Average Price (2003-2017) 114
5.7 Cardiac Rhythm Management Distribution Share (2009-2010) 115
5.8 Cardiac Rhythm Management, United States, Company Share (2009-2010) 116
6 Cardiovascular Monitoring and Diagnostic Devices In United States 118
6.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 118
6.2 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue Mix ($m), 2010 119
6.3 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Segment Contribution (%), 2010 120
6.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2003-2017) 121
6.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2003-2017) 125
6.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2003-2017) 129
6.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2009-2010) 131
6.8 Cardiovascular Monitoring and Diagnostic Devices, United States, Company Share (2009-2010) 132
7 Cardiovascular Prosthetic Devices In United States 134
7.1 Cardiovascular Prosthetic Devices, Market Segmentation 134
7.2 Cardiovascular Prosthetic Devices Market, United States, Revenue Mix ($m), 2010 135
7.3 Cardiovascular Prosthetic Devices Market, United States, Segment Contribution (%), 2010 136
7.4 Cardiovascular Prosthetic Devices Overall Revenue (2003-2017) 137
7.4.1 Septal Occluders Revenue (2003-2017) 141
7.5 Cardiovascular Prosthetic Devices Overall Volume (2003-2017) 145
7.5.1 Septal Occluders Volume (2003-2017) 149
7.6 Cardiovascular Prosthetic Devices Average Price (2003-2017) 153
7.7 Cardiovascular Prosthetic Devices Distribution Share (2009-2010) 154
7.8 Cardiovascular Prosthetic Devices, United States, Company Share (2009-2010) 155
8 Cardiovascular Surgery In United States 157
8.1 Cardiovascular Surgery, Market Segmentation 157
8.2 Cardiovascular Surgery Market, United States, Revenue Mix ($m), 2010 158
8.3 Cardiovascular Surgery Market, United States, Segment Contribution (%), 2010 159
8.4 Cardiovascular Surgery Overall Revenue (2003-2017) 160
8.4.1 Beating Heart Surgery Systems Revenue (2003-2017) 164
8.4.2 Perfusion Disposables Revenue (2003-2017) 168
8.5 Cardiovascular Surgery Overall Volume (2003-2017) 172
8.5.1 Beating Heart Surgery Systems Volume (2003-2017) 176
8.5.2 Perfusion Disposables Volume (2003-2017) 180
8.6 Cardiovascular Surgery Average Price (2003-2017) 184
8.7 Cardiovascular Surgery Distribution Share (2009-2010) 185
8.8 Cardiovascular Surgery, United States, Company Share (2009-2010) 186
9 Electrophysiology In United States 188
9.1 Electrophysiology, Market Segmentation 188
9.2 Electrophysiology Market, United States, Revenue Mix ($m), 2010 189
9.3 Electrophysiology Market, United States, Segment Contribution (%), 2010 190
9.4 Electrophysiology Overall Revenue (2003-2017) 191
9.5 Electrophysiology Overall Volume (2003-2017) 195
9.6 Electrophysiology Average Price (2003-2017) 199
9.7 Electrophysiology Distribution Share (2009-2010) 200
9.8 Electrophysiology, United States, Company Share (2009-2010) 201
10 External Defibrillators In United States 203
10.1 External Defibrillators, Market Segmentation 203
10.2 External Defibrillators Market, United States, Revenue Mix ($m), 2010 204
10.3 External Defibrillators Market, United States, Segment Contribution (%), 2010 205
10.4 External Defibrillators Overall Revenue (2003-2017) 206
10.5 External Defibrillators Overall Volume (2003-2017) 210
10.6 External Defibrillators Average Price (2003-2017) 214
10.7 External Defibrillators Distribution Share (2009-2010) 215
10.8 External Defibrillators, United States, Company Share (2009-2010) 216
11 Interventional Cardiology In United States 217
11.1 Interventional Cardiology, Market Segmentation 217
11.2 Interventional Cardiology Market, United States, Revenue Mix ($m), 2010 218
11.3 Interventional Cardiology Market, United States, Segment Contribution (%), 2010 219
11.4 Interventional Cardiology Overall Revenue (2003-2017) 220
11.4.1 Cardiac Catheters Revenue (2003-2017) 224
11.4.2 Coronary Stents Revenue (2003-2017) 228
11.4.3 PTCA Balloons Revenue (2003-2017) 232
11.4.4 Intravascular Ultrasound Systems (IVUS) Revenue (2003-2017) 236
11.5 Interventional Cardiology Overall Volume (2003-2017) 240
11.5.1 Cardiac Catheters Volume (2003-2017) 244
11.5.2 Coronary Stents Volume (2003-2017) 247
11.5.3 PTCA Balloons Volume (2003-2017) 250
11.5.4 Intravascular Ultrasound Systems (IVUS) Volume (2003-2017) 254
11.6 Interventional Cardiology Average Price (2003-2017) 258
11.7 Interventional Cardiology Distribution Share (2009-2010) 260
11.8 Interventional Cardiology, United States, Company Share (2009-2010) 261
11.8.1 Cardiac Catheters, United States, Company Share (2009-2010) 263
11.8.2 Coronary Stents, United States, Company Share (2009-2010) 264
12 Peripheral Vascular Devices In United States 265
12.1 Peripheral Vascular Devices, Market Segmentation 265
12.2 Peripheral Vascular Devices Market, United States, Revenue Mix ($m), 2010 266
12.3 Peripheral Vascular Devices Market, United States, Segment Contribution (%), 2010 267
12.4 Peripheral Vascular Devices Overall Revenue (2003-2017) 268
12.4.1 Stent Grafts Revenue (2003-2017) 272
12.4.2 Inferior Vena Cava Filters (IVCF) Revenue (2003-2017) 276
12.4.3 Peripheral Vascular Stents Revenue (2003-2017) 280
12.5 Peripheral Vascular Devices Overall Volume (2003-2017) 284
12.5.1 Stent Grafts Volume (2003-2017) 288
12.5.2 Inferior Vena Cava Filters (IVCF) Volume (2003-2017) 291
12.5.3 Peripheral Vascular Stents Volume (2003-2017) 295
12.6 Peripheral Vascular Devices Average Price (2003-2017) 299
12.7 Peripheral Vascular Devices Distribution Share (2009-2010) 301
12.8 Peripheral Vascular Devices, United States, Company Share (2009-2010) 302
13 Prosthetic Heart Valves In United States 304
13.1 Prosthetic Heart Valves, Market Segmentation 304
13.2 Prosthetic Heart Valves Market, United States, Revenue Mix ($m), 2010 305
13.3 Prosthetic Heart Valves Market, United States, Segment Contribution (%), 2010 306
13.4 Prosthetic Heart Valves Overall Revenue (2003-2017) 307
13.4.1 Mechanical Heart Valves Revenue (2003-2017) 310
13.4.2 Tissue Heart Valves Revenue (2003-2017) 314
13.5 Prosthetic Heart Valves Overall Volume (2003-2017) 318
13.5.1 Mechanical Heart Valves Volume (2003-2017) 320
13.5.2 Tissue Heart Valves Volume (2003-2017) 324
13.6 Prosthetic Heart Valves Average Price (2003-2017) 328
13.7 Prosthetic Heart Valves Distribution Share (2009-2010) 329
13.8 Prosthetic Heart Valves, United States, Company Share (2009-2010) 330
14 Overview of Key Companies in United States Cardiovascular Devices Market 332
14.1 Medtronic, Inc. 332
14.1.1 Company Overview 332
14.1.2 Share in the United States Cardiovascular Devices Market 332
14.2 Boston Scientific Corporation 333
14.2.1 Company Overview 333
14.2.2 Share in the United States Cardiovascular Devices Market 333
14.3 St. Jude Medical, Inc. 334
14.3.1 Company Overview 334
14.3.2 Share in the United States Cardiovascular Devices Market 334
14.4 Abbott Laboratories 335
14.4.1 Company Overview 335
14.4.2 Share in the United States Cardiovascular Devices Market 335
14.5 Cordis Corporation 336
14.5.1 Company Overview 336
14.5.2 Share in the United States Cardiovascular Devices Market 336
14.6 C. R. Bard, Inc. 337
14.6.1 Company Overview 337
14.6.2 Share in the United States Cardiovascular Devices Market 337
14.7 Thoratec Corporation 338
14.7.1 Company Overview 338
14.8 Philips Healthcare 338
14.8.1 Company Overview 338
14.9 Sorin S.p.A. 338
14.9.1 Company Overview 338
14.10 ZOLL Medical Corporation 339
14.10.1 Company Overview 339
14.11 MAQUET GmbH & Co. KG 339
14.11.1 Company Overview 339
14.12 Edwards Lifesciences Corporation 339
14.12.1 Company Overview 339
14.13 Biosense Webster, Inc. 340
14.13.1 Company Overview 340
14.14 BIOTRONIK SE & Co. KG 340
14.14.1 Company Overview 340
14.15 Terumo Corporation 340
14.15.1 Company Overview 340
14.16 Covidien plc 341
14.16.1 Company Overview 341
14.17 GE Healthcare 341
14.17.1 Company Overview 341
14.18 Volcano Corporation 341
14.18.1 Company Overview 341
14.19 Cardiac Science Corporation 342
14.19.1 Company Overview 342
14.20 AGA Medical Holdings, Inc. 342
14.20.1 Company Overview 342
14.21 Welch Allyn Inc. 342
14.21.1 Company Overview 342
14.22 ev3 Inc. 343
14.22.1 Company Overview 343
14.23 CareFusion Corporation 343
14.23.1 Company Overview 343
14.24 OSI Systems, Inc. 344
14.24.1 Company Overview 344
14.25 Mortara Instrument, Inc. 344
14.25.1 Company Overview 344
14.26 Card Guard Scientific Survival, Ltd. 344
14.26.1 Company Overview 344
14.27 Berlin Heart GmbH 345
14.27.1 Company Overview 345
14.28 HeartWare International, Inc. 345
14.28.1 Company Overview 345
14.29 Teleflex Incorporated 345
14.29.1 Company Overview 345
14.30 Schiller AG 346
14.30.1 Company Overview 346
14.31 ABIOMED, Inc. 346
14.31.1 Company Overview 346
15 Cardiovascular Devices Market Pipeline Products 347
15.1 Cardiac Assist Devices Market Pipeline Products 347
15.1.1 Ventricular Assist Devices Market Pipeline Products 347
15.1.2 Total Artificial Heart Market Pipeline Products 348
15.2 Cardiac Rhythm Management Market Pipeline Products 349
15.2.1 Implantable Cardioverter Defibrillator Market Pipeline Products 349
15.2.2 Pacemaker Market Pipeline Products 350
15.2.3 Implantable Cardioverter Defibrillators Market Pipeline Products 351
15.3 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 352
15.4 Cardiovascular Prosthetic Devices Market Pipeline Products 355
15.4.1 Cardiac Valve Repairs Market Pipeline Products 355
15.4.2 Septal Occluders Market Pipeline Products 356
15.5 Cardiovascular Surgery Market Pipeline Products 357
15.6 Electrophysiology Market Pipeline Products 359
15.6.1 Electrophysiology Ablation Catheters Market Pipeline Products 359
15.6.2 Electrophysiology Diagnostic Catheters Market Pipeline Products 361
15.6.3 Electrophysiology Lab Systems Market Pipeline Products 361
15.7 Interventional Cardiology Market Pipeline Products 362
15.7.1 Coronary Stents Market Pipeline Products 362
15.7.2 PTCA Balloon Market Pipeline Products 366
15.7.3 Cardiac Catheter Market Pipeline Products 367
15.7.4 Coronary Guidewire Market Pipeline Products 368
15.7.5 Arteriotomy Closure Devices Market Pipeline Products 368
15.7.6 PTCA Coronary Drug Eluting Balloons (DEB) Market Pipeline Products 369
15.7.7 Intravascular Ultrasound Systems (IVUS) Market Pipeline Products 370
15.8 Peripheral Vascular Devices Market Pipeline Products 371
15.8.1 Stent Grafts Market Pipeline Products 371
15.8.2 Peripheral Vascular Stents Market Pipeline Products 373
15.8.3 PTA Balloons Market Pipeline Products 375
15.8.4 Synthetic Surgical Grafts Market Pipeline Products 376
15.8.5 Peripheral Guidewires Market Pipeline Products 376
15.8.6 Inferior Vena Cava Filters (IVCF) Market Pipeline Products 377
15.8.7 Peripheral Embolic Protection Devices Market Pipeline Products 378
15.8.8 PTA Peripheral Drug Eluting Balloons (DEB) Market Pipeline Products 379
15.9 Prosthetic Heart Valves Market Pipeline Products 380
15.9.1 Tissue Heart Valves Market Pipeline Products 380
15.9.2 Mechanical Heart Valves Market Pipeline Products 381
15.9.3 Transcatheter Heart Valves Market Pipeline Products 382
16 Financial Deals Landscape 383
16.1 Acquisition 383
16.1.1 ValveXchange Receives Equity Investment from CryoLife 383
16.1.2 Flexible Stenting Solutions Receives Investment From Goodman 385
16.1.3 St. Jude Medical To Invest In Nanostim 386
16.1.4 Toshiba Medical Systems Completes Tender Offer To Acquire Vital Images For $273 Million 387
16.1.5 Baxter International To Acquire Prism Pharmaceuticals 389
16.1.6 Quest Diagnostics Completes Acquisition Of Celera 391
16.1.7 Biomedical Structures Acquires Concordia Medical 394
16.1.8 Veniti to Acquire Varix Medical and Teneo Medical 395
16.1.9 Physio-Control Acquires Jolife 396
16.1.10 Medtronic to Sell Physio-Control 398
16.1.11 Boston Scientific Acquires ReVascular Therapeutics 399
16.1.12 Cybersonics Acquires Omnisonics Medical Technologies 400
16.1.13 Boston Scientific Completes Acquisition Of Atritech 401
16.1.14 Teleflex Acquires VasoNova 404
16.1.15 Edwards Lifesciences Completes Acquisition Of Embrella Cardiovascular 406
16.1.16 Medtronic Completes Acquisition Of Remaining Stake In Ardian 408
16.1.17 Boston Scientific Completes Acquisition Of Remaining Stake In Sadra Medical 410
16.2 Partnerships 413
16.2.1 Bioheart Enters Into Licensing Agreement With Airspeed Equity 413
16.2.2 Vicor Technologies Enters Into Licensing Agreement With ZOLL Medical 414
16.2.3 NSVascular Enters Into Licensing Agreement With University of California 415
16.2.4 LiDCO Signs Licensing Agreement With ICU Medical 416
16.2.5 Aria CV Enters Into Licensing Agreement With University Of Minnesota 417
16.2.6 Christie Medical Enters Into An Agreement With Eclipse Aesthetics 418
16.2.7 Luna Innovations Expands Its Licensing Agreement With Hansen Medical 419
16.2.8 Accumetrics Signs Distribution Agreement With Cardinal Health 420
16.2.9 Rhythmia Medical Enters Into Joint Development Agreement With Endosense 421
16.2.10 Acacia Research Enters Into Licensing Agreement With SMITHS MEDICAL ASD 422
16.2.11 Acacia Research Enters Into Licensing Agreement With Becton, Dickinson And Argon Medical 423
16.2.12 International Cardio Enters Into Licensing Agreement With University of Minnesota 424
16.2.13 Boston Scientific Enters Into Partnership With Greatbatch Medical 425
16.2.14 American Hospital Management Enters Into Joint Venture Agreement With Royal St. Kitts Beach Resort 426
16.2.15 Physio-Control Enters Into Strategic Partnership With BeneChill 427
16.2.16 APICA Cardiovascular Enters Into Licensing Agreement With Georgia Institute And Emory University 428
17 Recent Developments 429
17.1 Strategy and Business Planning 429
17.1.1 Jul 29, 2011: WorldHeart to End Levacor VAD Program 429
17.1.2 Jun 27, 2011: Cook Medical Expands Asia-Pacific Distribution Centre In China To Meet Regional Surge In Growth Of Medical Device Market 429
17.1.3 Jun 15, 2011: Cordis Announces Discontinuation Of NEVO Sirolimus-Eluting Coronary Stent 430
17.1.4 May 20, 2011: LeMaitre To Consolidate California Factory 431
17.1.5 May 09, 2011: Cook Expands Raw Materials Manufacturing To Canton, Illinois 431
17.1.6 May 05, 2011: Medtronic Opens New Distribution Center In Mira Loma, California 432
17.1.7 Mar 08, 2011: Medtronic Inaugurates New Regional Headquarters Building In Greater China 432
17.1.8 Feb 10, 2011: C. R. Bard To Reduce Workforce By 20% 433
17.1.9 Feb 10, 2011: J&J Cordis Reduces Workforce In US 433
17.1.10 Jan 27, 2011: Greatbatch Medical To Build New Facility In Fort Wayne 433
17.1.11 Jan 10, 2011: Vasomedical Launches Online Store 433
17.1.12 Dec 13, 2010: Bard To Improve Overall Cost Structure And Enhance Operational Effectiveness 434
17.1.13 Nov 30, 2010: Hansen Opens European Commercialization And Training Center 434
17.1.14 Nov 09, 2010: Medtronic Opens New Distribution Center In Elizabeth, New Jersey 435
17.1.15 Oct 21, 2010: Collagen Matrix Expands Operations And Moves Corporate Headquarters To Oakland, New Jersey 435
17.1.16 Oct 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units 435
17.1.17 Oct 07, 2010: AT&T, eCardio Team Up To Advance Cardiac Care Through Innovative Mobile Technology 436
17.1.18 Oct 04, 2010: Edwards Lifesciences Opens New Facility In Utah 437
17.1.19 Sep 29, 2010: Edwards Lifesciences To Open New Manufacturing Facility In Utah 438
17.1.20 Sep 24, 2010: Merit Medical To Commence Construction Of New Building On South Jordan Campus 438
17.1.21 Aug 19, 2010: Boston Scientific To Invest In New Products: CEO 438
17.1.22 Aug 16, 2010: Orchid Expands Cleaning And Packaging Capabilities In Southfield, Michigan 438
17.1.23 Aug 09, 2010: Orthofix To Open New North American Operations And Education Center In Texas 439
17.2 Legal and Regulatory 440
17.2.1 Jul 12, 2011: Acacia Subsidiary Enters Into Settlement Agreement With Boston Scientific 440
17.2.2 Jun 07, 2011: Boston Scientific Gets Favorable Court Ruling Affirming Invalidity Of J&J Patents 440
17.2.3 May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction 440
17.2.4 May 11, 2011: Boston Scientific Announces Favorable Jury Verdict Against Cordis In Stent Patent Litigation 441
17.2.5 May 03, 2011: U.S. Senate Finance Committee Announces Investigation Against Medtronic 441
17.2.6 Apr 27, 2011: Acacia Subsidiary Enters Into Settlement Agreement With Cordis 441
17.2.7 Apr 25, 2011: St. Jude Medical Wins $2.3 Billion In Trade Secret Infringement Lawsuit Against Nervicon 441
17.2.8 Apr 07, 2011: J&J To Pay $70m To Settle Cases Brought By SEC And Criminal Authorities 442
17.2.9 Feb 08, 2011: Medtronic Issues Statement On District Court Ruling Regarding CoreValve 442
17.2.10 Feb 08, 2011: Edwards Lifesciences Issues Statment Regarding US Court Ruling 443
17.2.11 Jan 28, 2011: Boston Scientific Responds To DOJ Civil Lawsuit 443
17.2.12 Jan 28, 2011: Federal Jury In Marshall, Texas Returns $482 Million Verdict For Dickstein Shapiro Client 443
17.2.13 Jan 27, 2011: US Files Suit Against Guidant And Boston Scientific For Selling Defective Heart Devices That Were Implanted In Medicare Patients 443
17.2.14 Jan 20, 2011: St. Jude Medical Reaches Settlement With DOJ 444
17.2.15 Jan 12, 2011: Guidant To Pay Criminal Penalty Of More Than $296 Million And Three Years Probation 445
17.2.16 Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol 446
17.2.17 Jan 07, 2011: Judge Dismisses Class Action Lawsuit Against Medtronic Over Product Problem Issues 446
17.2.18 Dec 09, 2010: VNUS Reports Jury Returns Verdict In VNUS' Lawsuit With TVS And biolitec 446
17.2.19 Nov 10, 2010: St. Jude Medical And AGA Medical Announce Early Termination Of HSR Waiting Period 447
17.2.20 Nov 02, 2010: CSI Settles Employee Lawsuit With ev3 447
17.2.21 Nov 01, 2010: Ela Medical To Pay $9.2 Million To Resolve Kickbacks Claims 447
17.2.22 Nov 01, 2010: AGA Medical Investor Files Lawsuit Against Buyout 447
17.2.23 Oct 22, 2010: Sorin Announces Full And Final Settlement Of Investigation By DOJ 448
17.2.24 Oct 19, 2010: Howard G. Smith Investigates Proposed Acquisition Of Cardiac Science By OCI 449
17.2.25 Oct 18, 2010: Robbins Umeda Investigates Acquisition Of AGA Medical By St. Jude Medical 449
17.2.26 Oct 14, 2010: Medtronic Settles US Lawsuits On Sprint Fidelis Family Of Defibrillation Leads 449
17.2.27 Oct 04, 2010: Guide Flow Sues Six Companies Over Catheter Patent 450
17.2.28 Oct 04, 2010: Wall Cardiovascular Settles With Medtronic, Boston Scientific Over Stent Patent 450
17.2.29 Sep 28, 2010: Boston Scientific Urges Federal Court To Dismiss Guidant Lawsuit 450
17.2.30 Sep 23, 2010: St. Jude Medical Faces Derivative Suit From Shareholders 450
17.2.31 Sep 22, 2010: AIC Must Pay Out On $50 Million Policy In St. Jude Medical’s Silzone Case 451
17.2.32 Sep 20, 2010: Volcano Files Counterclaim Asserting St. Jude Infringes Three Patents 451
17.2.33 Sep 20, 2010: ConMed Files Complaint Against Former Sales Consultant 452
17.2.34 Sep 16, 2010: Minnesota Appeals Court Denies Appeal Of Medtronic Sprint Fidelis Case 452
17.2.35 Aug 26, 2010: St. Jude Medical In Talks With DOJ Kickbacks Case 452
17.2.36 Aug 24, 2010: AGA Medical Sues W.L. Gore & Associates For Patent Infringement 452
17.2.37 Aug 24, 2010: AtriCure might Resolve Class Action Lawsuit For $2.8 Million 452
17.2.38 Aug 18, 2010: Atrium Responds To Bard Suit 453
17.2.39 Aug 11, 2010: CardioNet Provides Update On Class Action Litigation 453
17.2.40 Aug 11, 2010: Endologix Responds To Patent Infringement Disputes With Bard Peripheral 453
17.3 Government and Public Interest 454
17.3.1 Jul 18, 2011: BG Medicine Receives ISO 13485 Certification 454
17.3.2 Jul 13, 2011: New Method Defibrillates Heart With Less Electricity, Pain: Cornell University 454
17.3.3 Jul 11, 2011: Mayo Clinic's VAD Program Offers Hope For Heart Failure Patients 455
17.3.4 Jul 10, 2011: MGH Researchers Develop One-Micrometer-Resolution Version Of Intravascular Imaging Technology 456
17.3.5 Jun 29, 2011: Hospira Supports North Carolina's New Legislation Aimed At Reducing Healthcare-Associated Infections 457
17.3.6 Jun 28, 2011: New Study Shows Viability Of Heart Pumps For Older Heart-Failure Patients 458
17.3.7 Jun 27, 2011: Boston Scientific Applauds Passage Of Patent Reform Bill 459
17.3.8 Jun 24, 2011: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Invasive Hemodynamic Monitoring Products And Accessories 459
17.3.9 Jun 21, 2011: Spaulding Clinical Quality Management System Achieves ISO 13485 Certification 459
17.3.10 Jun 20, 2011: Teleflex Resolves FDA Corporate Warning Letter 460
17.3.11 Jun 14, 2011: FDA Recalls Boston Scientific's Atlantis SR Pro2 Coronary Imaging Catheters In Addition To iCross Catheters 460
17.3.12 Jun 13, 2011: Echocardiography Shows Promise In Guiding Gene Therapy For Disease Prevention And Treatment 460
17.3.13 May 26, 2011: Drug-Eluting Stents Using Biodegradable Polymer Significantly Improve Overall Clinical Outcomes 461
17.3.14 May 06, 2011: Study Shows Stents Are Superior To Balloons Alone For Patients With Deep Venous Thrombosis 462
17.3.15 May 05, 2011: SCAI Releases First Report On Transradial Access For Angioplasty And Stenting 462
17.3.16 May 05, 2011: HERCULES Trial Demonstrates Significant Reduction In Systolic Blood Pressure While Revealing Marker In Hypertensive Patients Does Not Predict Outcomes Of Renal Artery Stenting 463
17.3.17 May 05, 2011: Specialized Signals Inside ICDs Provide Ongoing Monitoring For High-Risk Patients: Study 464
17.3.18 May 03, 2011: Premier, BIOTRONIK To Offer Savings Opportunities For CRM Devices 465
17.3.19 Apr 29, 2011: Defibtech Announces Voluntary Recall Of DDU-100 Series AEDs 465
17.3.20 Apr 27, 2011: CareCore National Recommends Adoption of Prior Authorization to Improve Patient Outcomes And Curb Healthcare Spend 466
17.3.21 Apr 16, 2011: New Patient Guidelines for Heart Devices Presented At International Society Of Heart And Lung Transplantation Annual Meeting 466
17.3.22 Apr 14, 2011: Progress In Development Of Mechanical Circulatory Support Devices For Children To Be Presented At ISHLT Annual Meeting 467
17.3.23 Apr 14, 2011: St Jude Medical Receives FDA And CE Mark Approvals For ShockGuard Technology 468
17.3.24 Apr 11, 2011: Philips Medical Systems Receives Amended Warning Letter From FDA 468
17.3.25 Apr 03, 2011: New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery 469
17.3.26 Mar 23, 2011: Mayo Clinic Researchers Find Cardiac Pacing Helps Epilepsy Patients With Ictal Asystole 470
17.3.27 Mar 22, 2011: Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree with FDA Regarding Quality System Improvements 471
17.3.28 Mar 21, 2011: Millar Instruments Issues Recall Of Millar Mikro-Tip Angiographic Catheter, Model SPC-454D And SPC-454F 471
17.3.29 Mar 14, 2011: Winthrop-University Hospital Implants Revo MRI Surescan Pacing System 472
17.3.30 Mar 09, 2011: Medtronic Resolves FDA Warning Letters 472
17.3.31 Mar 03, 2011: Analysis Of SAPPHIRE Data In March Issue Of CCI Supports CAS As Cost-Effective Alternative To CEA 473
17.3.32 Mar 01, 2011: Women Get Short Shrift In Many Heart Device Studies, Despite Requirement: Study 474
17.3.33 Feb 03, 2011: Abiomed Announces Survey Results And Launches National Heart Recovery Awareness Campaign 475
17.3.34 Jan 26, 2011: Texas Heart Institute At St. Luke’s Episcopal Hospital First In Texas To Offer New Cardiology Procedure To Eliminate A Major Cause Of Heart-Related Stroke 475
17.3.35 Jan 25, 2011: Occurrence Of Stroke After CABG Surgery Appears To Be Decreasing: Study 476
17.3.36 Jan 24, 2011: University Of Michigan, University Of Pittsburgh To Lead REVIVE-IT Study With $13.3 Million In Support From NHLBI, HeartWare 477
17.3.37 Jan 21, 2011: FDA To Implement Stricter Approval Process For Defibrillators 478
17.3.38 Jan 20, 2011: Spectranetics Receives FDA Approval For Site Change Related To Manufacturing Of CVX-300 Laser System 478
17.3.39 Jan 19, 2011: SCAI Publishes Radiation Safety Program Principles For Cardiac Catheterization Labs 479
17.3.40 Jan 04, 2011: Many Patients With ICDs Do Not Meet Criteria For Use: JAMA Study 480
17.4 Product News 481
17.4.1 Jul 13, 2011: Toshiba Installs Infinix CF-i Bi-Plane System With CAT-880B Hybrid Catheterization Table At Arnold Palmer Hospital for Children In Orlando, Florida 481
17.4.2 Jul 12, 2011: Boston Scientific Completes Clinical Trial Enrollment For Adapt Monorail Carotid Stent System 482
17.4.3 Jan 21, 2011: Cardiac Science Extends Device Connectivity To Allscripts Professional Electronic Health Record 482
17.4.4 Oct 26, 2010: eCardio Plans To Streamline Products 483
17.4.5 Sep 10, 2010: CorMatrix Receives FDA IDE Approval To Begin Clinical Evaluation Of New Onset Postoperative Atrial Fibrillation In Subjects Receiving CorMatrix ECM For Pericardial Closure 484
17.4.6 Sep 01, 2010: ZOLL To Showcase LifeVest Wearable Defibrillator At The Heart Failure Society Of America Annual Meeting 484
17.4.7 Aug 04, 2010: Beaumont Hospital Physicians Screens High School Students Using GE Healthcare’s MAC 800 ECG 485
17.4.8 Jul 20, 2010: Spectranetics Announces Reimbursement Approval For Laser-Assisted Lead Extraction In Japan 486
17.4.9 Jul 12, 2010: BIOTRONIK Unveils Final Results Of TRUST Trial For BIOTRONIK Home Monitoring 486
18 Appendix 488
18.1 Definitions of Markets Covered in the Report 489
18.1.1 Cardiovascular Devices 489
18.2 Secondary Research 499
18.3 Primary Research 499
18.4 Models 500
18.5 Forecasts 500
18.6 Expert Panels 500
18.7 GlobalData Consulting 500
18.8 Currency Conversion 501
18.9 Contact Us 501
18.10 Disclaimer 501
1.1 List of Tables
Table 1: Cardiovascular Devices, United States, Overall Revenue ($m), 2003-2017 31
Table 2: Cardiovascular Devices Market, United States, Category Contribution (%), 2010 33
Table 3: Cardiovascular Devices, United States, Cross-Category Analysis, 2003-2017 35
Table 4: Cardiovascular Devices, United States, Overall Revenue ($m), Historic, 2003-2010 37
Table 5: Cardiovascular Devices, United States, Overall Revenue ($m), Forecast, 2010-2017 39
Table 6: Cardiovascular Devices, United States, Category Volume (Units), 2003-2017 41
Table 7: Cardiovascular Devices, United States, Category Volume (Units), Historic, 2003-2010 43
Table 8: Cardiovascular Devices, United States, Category Volume (Units), Forecast, 2010-2017 45
Table 9: Cardiovascular Devices, United States, Company Share by Revenue ($m), 2009-2010 47
Table 10: Cardiac Assist Devices Market, United States, Segment Contribution (%), 2010 50
Table 11: Cardiac Assist Devices, United States, Revenue ($m) by Segment, Historic, 2003-2010 52
Table 12: Cardiac Assist Devices, United States, Revenue ($m) by Segment, Forecast, 2010-2017 54
Table 13: Intra-Aortic Balloon Pumps, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Table 14: Intra-Aortic Balloon Pumps, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Table 15: Ventricular Assist Devices, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 60
Table 16: Ventricular Assist Devices, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 62
Table 17: Cardiac Assist Devices, United States, Volume (Units) by Segment, Historic, 2003-2010 64
Table 18: Cardiac Assist Devices, United States, Volume (Units) by Segment, Forecast, 2010-2017 66
Table 19: Intra-Aortic Balloon Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 68
Table 20: Intra-Aortic Balloon Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 70
Table 21: Ventricular Assist Devices, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 72
Table 22: Ventricular Assist Devices, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 74
Table 23: Cardiac Assist Devices, United States, Average Price ($), Historic, 2003-2010 75
Table 24: Cardiac Assist Devices, United States, Average Price ($), Forecast, 2010-2017 76
Table 25: Cardiac Assist Devices, United States, Distribution Share by Revenue ($m), 2009-2010 77
Table 26: Cardiac Assist Devices, United States, Company Share by Revenue ($m), 2009-2010 79
Table 27: Cardiac Rhythm Management Market, United States, Segment Contribution (%), 2010 82
Table 28: Cardiac Rhythm Management, United States, Revenue ($m) by Segment, Historic, 2003-2010 84
Table 29: Cardiac Rhythm Management, United States, Revenue ($m) by Segment, Forecast, 2010-2017 86
Table 30: Cardiac Resynchronisation Therapy, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 88
Table 31: Cardiac Resynchronisation Therapy, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 90
Table 32: Implantable Cardioverter Defibrillators, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 92
Table 33: Implantable Cardioverter Defibrillators, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 94
Table 34: Pacemakers, United States, Revenue ($m) by Sub-Segment, Historic, 2003-2010 96
Table 35: Pacemakers, United States, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 98
Table 36: Cardiac Rhythm Management, United States, Volume (Units) by Segment, Historic, 2003-2010 100
Table 37: Cardiac Rhythm Management, United States, Volume (Units) by Segment, Forecast, 2010-2017 102
Table 38: Cardiac Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 104
Table 39: Cardiac Resynchronisation Therapy, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 106
Table 40: Implantable Cardioverter Defibrillators, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 108
Table 41: Implantable Cardioverter Defibrillators, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 110
Table 42: Pacemakers, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 112
Table 43: Pacemakers, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 113
Table 44: Cardiac Rhythm Management, United States, Average Price ($), Historic, 2003-2010 114
Table 45: Cardiac Rhythm Management, United States, Average Price ($), Forecast, 2010-2017 114
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article